Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The SPRAINED Study is a multi-centre observational cohort study of acute ankle sprains that present to NHS Emergency Departments. The study is validating a prognostic tool for use in Emergency Departments for patients with acute ankle sprain to identify those in whom recovery may be substantially prolonged or incomplete and additional investigations or treatment is indicated. The study was funded by the NIHR HTA (project number 13/19/06) and opened to recruitment in July 2015 to March 2016.

Recruitment was initially slow as the 10 participating sites progressively opened in the summer months of 2015. However, recruitment accelerated rapidly through autumn 2015 with all sites active and the momentum was maintained to slightly exceed our target of 675 with 682 participants recruited. The study is now in follow-up with patient reported outcomes being collected throughout 2016 at 4 weeks, 4 months, and 9 months following the patient’s ankle sprain. The final results will be available in 2017. 

Similar stories

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.

HUSH trial opens to recruitment!

OCTRU

The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!

Oxford researchers start new trial on the use of anti-TNF to treat Covid-19 in care homes

Main OCTRU Trials

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.